By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Bio-Reference Laboratories today said that it has signed a definitive agreement to collaborate with Massachusetts General Hospital on developing pharmacogenomic tests for cancer.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.
The new Riken president outlines some of his plans for the institute.
The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.
An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.